Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Svein R. Kjosavik, Karina Dalsgaard Sørensen, Kristina Hotakainen & Henrik Grönberg. (2020) A Nordic initiative for a more personal and accurate diagnostic pathway for prostate cancer. Scandinavian Journal of Primary Health Care 38:3, pages 249-250.
Read now
Read now
Articles from other publishers (6)
Vincent J. Gnanapragasam, David Greenberg & Neil Burnet. (2022) Urinary symptoms and prostate cancer—the misconception that may be preventing earlier presentation and better survival outcomes. BMC Medicine 20:1.
Crossref
Crossref
Visalini Nair-Shalliker, Albert Bang, Sam Egger, Xue Qin Yu, Karen Chiam, Julia Steinberg, Manish I. Patel, Emily Banks, Dianne L. O’Connell, Bruce K. Armstrong & David P. Smith. (2022) Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study. British Journal of Cancer 127:4, pages 735-746.
Crossref
Crossref
Nina Petrović, Tatjana P. Stanojković & Marina Nikitović. (2022) MicroRNAs in Prostate Cancer Following Radiotherapy: Towards
Predicting Response to Radiation Treatment. Current Medicinal Chemistry 29:9, pages 1543-1560.
Crossref
Crossref
Abin AbrahamNicholas L. KavoussiWilson SuiCosmin BejanJohn A. CapraRyan Hsi. (2022) Machine Learning Prediction of Kidney Stone Composition Using Electronic Health Record-Derived Features. Journal of Endourology 36:2, pages 243-250.
Crossref
Crossref
Mari Carmen Bernal-Soriano, Lucy Anne Parker, Maite López-Garrigós, Ildefonso Hernández-Aguado, Luis Gómez-Pérez, Juan-Pablo Caballero-Romeu, María Pastor-Valero, Nuria García, Rocío Alfayate-Guerra & Blanca Lumbreras. (2021) Do the Prostate-Specific Antigen (PSA) Tests That Are Ordered in Clinical Practice Adhere to the Pertinent Guidelines?. Journal of Clinical Medicine 10:12, pages 2650.
Crossref
Crossref
Sung Gon Park, Kang Hee Shim, Seol Ho Choo, Se Joong Kim & Sun Il Kim. (2021) The presence of prostate-specific antigen checked more than 1 year before diagnostic biopsy is an independent prognostic factor in patients undergoing radical prostatectomy. Investigative and Clinical Urology 62:4, pages 438.
Crossref
Crossref